Authors

• Tudor–Eliade Ciuleanu (ORCID: https://orcid.org/0000-0003-0958-5597)
• Parul Doshi (ORCID: https://orcid.org/0000-0002-5399-5844)
• Jonathan Baden (ORCID: https://orcid.org/0000-0002-9423-8305)
• Somasekhar Konduru
• Michele Maio (ORCID: https://orcid.org/0000-0002-0323-6321)
• Patrick Schöffski (ORCID: https://orcid.org/0000-0001-5980-030X)
• Alexandra Léary (ORCID: https://orcid.org/0000-0002-2043-2244)
• Jean‐Pierre Delord (ORCID: https://orcid.org/0000-0001-7305-5561)
• Ruta Slepetis
• Michael Schenker (ORCID: https://orcid.org/0000-0003-2645-6391)
• Paolo A. Ascierto (ORCID: https://orcid.org/0000-0002-8322-475X)
• Quyen Duong
• Iwona Ługowska (ORCID: https://orcid.org/0000-0001-9511-178X)
• Marina Tschaika
• Neeltje Steeghs (ORCID: https://orcid.org/0000-0003-2989-2279)
• Lorena Lupinacci
• David S.P. Tan (ORCID: https://orcid.org/0000-0001-9087-5262)
• Misena Pacius
• Massimo Di Nicola (ORCID: https://orcid.org/0000-0002-7689-5774)
• Mauricio Burotto (ORCID: https://orcid.org/0000-0002-7150-4033)
• Julieta Grasselli
• Sai Vikram Vemula (ORCID: https://orcid.org/0009-0006-1022-7251)
• Martin Eduardo Richardet
• Jacqueline Vuky (ORCID: https://orcid.org/0000-0001-5795-3361)
• Georgia Kollia
• Ning Huang (ORCID: https://orcid.org/0000-0003-3331-8536)
• Jennifer Friedmann
• Anthony Gonçalves (ORCID: https://orcid.org/0009-0009-9335-6447)

Institutions

• University of Siena (IT)
• Oregon Health & Science University (US)
• National University of Singapore (SG)
• Iuliu Hațieganu University of Medicine and Pharmacy (RO)
• Université Paris-Saclay (FR)
• Jewish General Hospital (CA)
• Institut Gustave Roussy (FR)
• Hospital Italiano de Buenos Aires (AR)
• University of Medicine and Pharmacy of Craiova (RO)
• The Netherlands Cancer Institute (NL)
• Bristol-Myers Squibb (United States) (US)
• Institute of Oncology Prof. Dr. Ion Chiricuta (RO)
• National University Cancer Institute, Singapore (SG)
• Institut Claudius Regaud (FR)
• Instituto Oncológico de Córdoba (AR)
• National Cancer Centre Singapore (SG)
• Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR)
• Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
• Institut Paoli-Calmettes (FR)
• The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
• Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
• McGill University (CA)
• KU Leuven (BE)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2024-08-01

DOI

https://doi.org/10.1136/jitc-2024-008872

Citations

33

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

7.35

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Gilead Sciences
• Karyopharm Therapeutics
• Exelixis
• Les Laboratories Pierre Fabre
• Astex Pharmaceuticals
• Clovis Oncology
• Mylan
• BeiGene
• Incyte
• Actuate Therapeutics
• MacroGenics
• Department of Science and Technology, Ministry of Science and Technology, India
• Eisai
• Astellas Pharma
• Ono Pharmaceutical
• Genentech
• Samsung
• Medical Research Council
• National Medical Research Council
• Daiichi Sankyo Europe